Chemours (CC)
(Delayed Data from NYSE)
$26.26 USD
-2.62 (-9.07%)
Updated Mar 28, 2024 04:01 PM ET
After-Market: $26.26 0.00 (0.00%) 5:28 PM ET
2-Buy of 5 2
A Value C Growth D Momentum B VGM
Income Statements
Fiscal Year end for The Chemours Company falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 6,794 | 6,345 | 4,969 | 5,526 |
Cost Of Goods | NA | 5,178 | 4,964 | 3,902 | 4,463 |
Gross Profit | NA | 1,616 | 1,381 | 1,067 | 1,063 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 844 | 705 | 700 | 715 |
Income After Depreciation & Amortization | 0 | 772 | 676 | 367 | 348 |
Non-Operating Income | NA | 132 | 185 | 22 | -264 |
Interest Expense | NA | 163 | 185 | 210 | 208 |
Pretax Income | NA | 741 | 676 | 179 | -124 |
Income Taxes | NA | 163 | 68 | -40 | -72 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 578 | 608 | 219 | -52 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 578 | 608 | 219 | -52 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 1,072 | 1,002 | 696 | 668 |
Depreciation & Amortization (Cash Flow) | NA | 300 | 326 | 329 | 320 |
Income After Depreciation & Amortization | 0 | 772 | 676 | 367 | 348 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 158.30 | 168.70 | 166.35 | 167.25 |
Diluted EPS Before Non-Recurring Items | NA | 4.66 | 4.00 | 1.98 | 2.51 |
Diluted Net EPS (GAAP) | NA | 3.65 | 3.60 | 1.32 | -0.32 |
Fiscal Year end for The Chemours Company falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | NA | 1,487.00 | 1,643.00 | 1,536.00 | 1,338.00 |
Cost Of Goods | NA | 1,206.00 | 1,233.00 | 1,168.00 | 1,137.00 |
Gross Profit | NA | 281.00 | 410.00 | 368.00 | 201.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 317.00 | 806.00 | 166.00 | 211.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -36.00 | -396.00 | 202.00 | -10.00 |
Non-Operating Income | NA | 114.00 | 11.00 | 13.00 | -18.00 |
Interest Expense | NA | 55.00 | 48.00 | 42.00 | 41.00 |
Pretax Income | NA | 23.00 | -433.00 | 173.00 | -69.00 |
Income Taxes | NA | 3.00 | -57.00 | 28.00 | 28.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 20.00 | -376.00 | 145.00 | -97.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 20.00 | -376.00 | 145.00 | -97.00 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | NA | 150.19 | 150.61 | 151.18 | 152.22 |
Diluted EPS Before Non-Recurring Items | NA | 0.64 | 1.10 | 0.98 | 0.00 |
Diluted Net EPS (GAAP) | NA | 0.13 | -2.52 | 0.96 | -0.56 |